General Motors is celebrating 25 years of global success for GMC’s Denali sub-brand. The automaker’s truck and utility vehicle brand highlighted the first 25 years of the Denali trim level ...

GMC is celebrating the 25 th anniversary of the Denali trim with a new package for the 2025 Yukon Denali and Denali Ultimate. It adds a blacked out exterior with a dark grille, matching badging ...

The right image shows the configuration at approximately 52 million years ago, prior to 300 miles of Denali Fault movement. Credit: Geology (2024). DOI: 10.1130/G52614.1 ...

Stifel Nicolaus upgraded shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) from a hold rating to a buy rating in a research note released on Monday morning, Marketbeat Ratings reports.

A month has gone by since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares have lost about 21.2% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Then we also have the off-road focused AT4 variants for the Terrain, Acadia, Yukon, Canyon, Sierra, and Sierra HD, plus the ritzy Denali side of the equation for all six previous nameplates ...

Powering the 2025 GMC Sierra EV Denali is GM’s Ultium platform, which they have announced will be renamed soon. They estimate that in Max Power mode, the Sierra EV Denali puts out 760 hp and 785 ...

Stifel upgraded Denali Therapeutics (DNLI) to Buy from Hold with a $37 price target Denali recently aligned with the FDA to file for accelerated approval for their lead candidate DLN310 ...

The annual Denali Solstice Ski and Stroll will take place between 4-6 p.m. on Saturday at Denali National Park. This year, the screening of Alaska Wilderness Films is added to the event.

State Street Corp trimmed its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 4.1% in the third quarter, HoldingsChannel.com reports. The firm owned 4,252,011 shares of the ...

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical study, BEACON, of the ...